JMIR Formative Research

View query in Help articles search

Field

e.g. mhealth

Operator

Field

Criteria

e.g. John Smith or 0000-0001-6479-5330

Exact Match for Criteria

Yes No

Search Results (1 to 6 of 6 Results)

Download search results: CSV END BibTex RIS

Sort by:

Implementing a Patient Portal for the Remote Follow-Up of Self-Isolating Patients With COVID-19 Infection Through Patient and Stakeholder Engagement (the Opal-COVID Study): Mixed Methods Pilot Study

Yuanchao Ma, David Lessard, Serge Vicente, Kim Engler, Adriana Rodriguez Cruz, Moustafa Laymouna, Opal-COVID Patient Expert Committee, Tarek Hijal, Lina Del Balso, Guillaume Thériault, Nathalie Paisible, Nadine Kronfli, Marie-Pascale Pomey, Hansi Peiris, Sapha Barkati, Marie-Josée Brouillette, Marina Klein, Joseph Cox, Alexandra de Pokomandy, Jamil Asselah, Susan J Bartlett, Bertrand Lebouché

J Particip Med 2024;16:e48194

Download Citation: END BibTex RIS

Download PDF Download XML

Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review

Moustafa Laymouna, Yuanchao Ma, David Lessard, Tibor Schuster, Kim Engler, Bertrand Lebouché

J Med Internet Res 2024;26:e56930

Download Citation: END BibTex RIS

Download PDF Download XML

Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Since 2020, led by YM, SA, and B Lebouché, an innovative chatbot named Minimal Anti Retro Viral INterference (now named MARVIN) has been in development for people with HIV. Through a co-design approach involving patients and stakeholders, MARVIN aims to facilitate antiretroviral therapy self-management. The authors’ team subsequently trialed the MARVIN chatbot among people with HIV and validated its usability and acceptability [32].

Yuanchao Ma, Sofiane Achiche, Marie-Pascale Pomey, Jesseca Paquette, Nesrine Adjtoutah, Serge Vicente, Kim Engler, MARVIN chatbots MARVIN chatbots Patient Expert Committee, Moustafa Laymouna, David Lessard, Benoît Lemire, Jamil Asselah, Rachel Therrien, Esli Osmanlliu, Ma'n H Zawati, Yann Joly, Bertrand Lebouché